Sugi Predict

Sugi Predict / Compounds / SCHEMBL5354699

SCHEMBL5354699

SCHEMBL5354699

CCc1nc2cnc3ccccc3c2n1CCS(C)(=O)=O

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TLR7 Q9NYK1 6/20 0.47
▸ PDE10A Q9Y233 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ PTGER4 P35408 1/20 0.36
▸ PPARG P37231 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ TLR8 Q9NR97 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5349584 0.91 TLR7 (0.52) TLR7PDE10ARECQLTSHRMAPK1
SCHEMBL1896707 0.89 TLR7 (0.46) TLR7PDE10ARECQLTSHRMAPK1
SCHEMBL4320463 0.85 TLR7 (0.50) TLR7PDE10ARECQLTSHRMAPK1
SCHEMBL4310270 0.84 TLR7 (0.47) TLR7PDE10ARECQLTSHRMAPK1
SCHEMBL4317408 0.84 TLR7 (0.52) TLR7PDE10ARECQLTSHRMAPK1
SCHEMBL5797746 0.83 TLR7 (0.46) TLR7PDE10ARECQLTSHRMAPK1
SCHEMBL4322445 0.83 TLR7 (0.44) TLR7PDE10ARECQLTSHRMAPK1
SCHEMBL20796976 0.82 TLR7 (0.46) TLR7PDE10ARECQLTSHRMEN1
SCHEMBL3969176 0.82 TLR7 (0.68) TLR7MAPTALDH1A1PPARGTP53
SCHEMBL4322798 0.82 TLR7 (0.46) TLR7PDE10ARECQLTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7276515-B2 Thioether substituted imidazoquinolines COLEY PHARMACEUTICAL GROUP, INC. (US) 2007-10-02 — — US disclosed
US-6949649-B2 Thioether substituted imidazoquinolines 3M INNOVATIVE PROPERTIES CO. (US) 2005-09-27 — — US disclosed
US-20050209268-A1 Thioether substituted imidazoquinolines 3M INNOVATIVE PROPERTIES COMPANY 2005-09-22 — — US disclosed
EP-1451191-A1 THIOETHER SUBSTITUTED IMIDAZOQUINOLINES 3M Innovative Properties Company (US) 2004-09-01 — — EP disclosed
US-20040097736-A1 Thioether substituted imidazoquinolines 3M INNOVATIVE PROPERTIES COMPANY 2004-05-20 — — US disclosed
US-6667312-B2 Useful as immune response modifiers 3M INNOVATIVE PROPERTIES COMPANY 2003-12-23 — — US disclosed
WO-2003050121-A1 THIOETHER SUBSTITUTED IMIDAZOQUINOLINES 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-06-19 — — WO disclosed
US-20030100764-A1 Thioether substituted imidazoquinolines 3M INNOVATIVE PROPERTIES COMPANY 2003-05-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050209268-A1 Thioether substituted imidazoquinolines IFNG, IRF3, IL2 TLR7 30/4885PDE10A 4787/4885RECQL 1029/4885
US-20040097736-A1 Thioether substituted imidazoquinolines IFNG, IRF3, IL2 TLR7 30/4885PDE10A 4787/4885RECQL 1029/4885
US-20030100764-A1 Thioether substituted imidazoquinolines IFNG, IRF3, IL2 TLR7 30/4885PDE10A 4787/4885RECQL 1029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.